PSI Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
PSI Advisors's LLY Position: Q1 2026 in Review
PSI Advisors reduced its Eli Lilly (LLY) stake by 7% in Q1 2026, selling an estimated $394K and leaving 5,135 shares worth $4.72M. The position accounts for 1.13% of the portfolio, ranked #19.
PSI Advisors first reported a position in LLY in Q4 2019 and has held it in 26 quarters since. The position peaked at $5.94M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- PSI Advisors held 5,135 shares of Eli Lilly worth $4.72M as of Q1 2026.
- PSI Advisors sold 389 Eli Lilly shares in Q1 2026, an estimated $394K.
- Eli Lilly made up 1.13% of PSI Advisors's portfolio in Q1 2026, its #19 holding.
- PSI Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 26 quarters since.
- PSI Advisors's Eli Lilly position peaked at $5.94M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on PSI Advisors's 13F filing for Q1 2026, filed 15 May 2026.